StockNews com Begins Coverage on Bellicum Pharmaceuticals (NASDAQ:BLCM) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com initiated coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a research report released on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Price Performance Shares of NASDAQ:BLCM opened at $0.19 on Monday. Bellicum Pharmaceuticals has a fifty-two week low of $0.06 and a fifty-two […]
Bellicum Pharmaceuticals (NASDAQ:BLCM) Now Covered by Analysts at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a report released on Saturday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Trading Down 20.0 % Shares of BLCM opened at $0.20 on Friday. The stock has a fifty day moving average price of $0.21 […]